Publication Cover
Natural Product Research
Formerly Natural Product Letters
Volume 29, 2015 - Issue 19
273
Views
10
CrossRef citations to date
0
Altmetric
Articles

A new anthraquinone from Morinda elliptica Ridl.

, , , , &
Pages 1833-1838 | Received 16 Sep 2014, Accepted 12 Jan 2015, Published online: 17 Feb 2015

References

  • Abboud P, Lemee V, Gargala G, Brasseur P, Ballet JJ, Borsa-Lebas F, Caron F, Favennec L. 2001. Successful treatment of metronidazole- and albendazole-resistant giardiasis with nitazoxanide in a patient with acquired immunodeficiency syndrome. Clin Infect Dis. 32:1792–1794. doi:10.1086/320751.
  • Balakrishna S, Seshadri TR, Venkatarumani B. 1960. Special chemical components of commercial woods and related plant material IX moridonin, a new glycoside of morindone. J Sci Ind Res B. 19:433–436.
  • Brisson C, Brassard P. 1981. Regiospecific reactions of some vinylogous ketene acetals with haloquinones and their regioselective formation by dienolization. J Org Chem. 46:1810–1814. doi:10.1021/jo00322a012.
  • Bueid A, Howard SJ, Moore CB, Richardson MD, Harrison E, Bowyer P, Denning DW. 2010. Azole antifungal resistance in Aspergillus fumigatus: 2008 and 2009. J Antimicrob Chemother. 65:2116–2118, doi:10.1093/jac/dkq279.
  • Burnett AR, Thomson RH. 1968. Anthraquinones in Morinda umbellate L. Phytochemitry. 7:1421–1422. doi:10.1016/S0031-9422(00)85651-4.
  • Chang P, Lee KH. 1984. Cytotoxic antileukemic anthraquinones from Morida parvifolia. Phytochemistry. 23:1733–1736. doi:10.1016/S0031-9422(00)83480-9.
  • Chang P, Lee KH. 1985. Antitumor agents, 75. Synthesis of cytotoxic anthraquinones digiferruginol and morindaparvin-B. J Nat Prod. 48:948–951. doi:10.1021/np50042a011.
  • Clinical and Laboratory Standards Institute. 2000. Reference method for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard M7-A4. Pennsylvania, PA: Clinical Laboratory Standards Institute.
  • Clinical and Laboratory Standards Institute. 2002a. Reference method for broth dilution antifungal susceptibility testing of yeasts: approved standard-second edition. CLSI documents M27-A2. Pennsylvania, PA: Clinical Laboratory Standards Institute.
  • Clinical and Laboratory Standards Institute. 2002b. Reference method for broth dilution antifungal susceptibility testing of filamentous fungi: approved standard. CLSI documents M38-A. Pennsylvania, PA: Clinical Laboratory Standards Institute.
  • Danielsen K, Aksnes DW, Francis GW. 1995. The complete assignment of the 1H and 13C chemical shift of 1,2-diacetoxy-9,10-anthraquinone. Acta Chem Scand. 49:464–466. doi:10.3891/acta.chem.scand.49-0464.
  • Doyle JS, Buising KL, Thursky KA, Worth LJ, Richards MJ. 2011. Epidemiology of infections acquired in intensive care units. Semin Respir Crit Care Med. 32:115–138. doi:10.1055/s-0031-1275525.
  • Faltynek CR, Schroeder J, Mauvais P, Miller D, Wang S, Murphy D, Lehr R, Kelley M, Maycock A. 1995. Damnacanthal is a highly potent, selective inhibitor of p56lck tyrosine kinase activity. Biochemistry. 34:12404–12410. doi:10.1021/bi00038a038.
  • Favre-Godal Q, Dorsaz S, Queiroz EF, Conan C, Marcourt L, Wardojo BP, Voinesco F, Buchwalder A, Gindro K, Sanglard D, Wolfender JL. 2014. Comprehensive approach for the detection of antifungal compounds using a susceptible strain of Candida albicans and confirmation of in vivo activity with the Galleria mellonella model. Phytochemistry. 105:68–78. doi:10.1016/j.phytochem.2014.06.004.
  • Feng Z, Sujuan W, Sheng L, Chenggen Z, Zhenggang Y, Yang Y, Bo L, Xiuli W, Yongchun Y, Yan L, Jiangong S. 2012. Natural and unnatural anthraquinones isolated from the ethanol extract of the roots of Knoxia valerianoides. Acta Pharm Sin B. 2(3):260–266. doi:10.1016/j.apsb.2012.03.004.
  • Inoue K, Nayeshiro H, Inouye H, Zenk M. 1981. Anthraquinones in cell suspension cultures of Morinda citrifolia. Phytochemistry. 20:1693–1700. doi:10.1016/S0031-9422(00).
  • Ismail NH, Ali AM, Aimi N, Kitajima M, Takayama H, Lajis NH. 1997. Anthraquinones from Morinda elliptica. Phytochemistry. 45:1723–1725. doi:10.1016/S0031-9422(97)00252-5.
  • Koumaglo K, Gbeassor M, Nikabu O, Werner W. 1992. Effects of three compounds extracted from Morinda lucida on Plasmodium falciparum. Planta Med. 58:533–534. doi:10.1055/s-2006-961543.
  • Noorjahan BMA, Ali AM, Yeap SK, Suhaimi M, Lajis NH, Mashitoh AR, Ho WY, Ismail NH. 2010. Cytotoxicity and immunomodulatory effects of damnacanthal and nordamnacanthal isolated from roots of Morinda elliptica. J Agrobiotech. 1:29–42.
  • Petri WA. 2003. Therapy of intestinal protozoa. Trends Parasitol. 19:523–526. http://dx.doi.org/10.1016/j.pt.2003.09.003.
  • Pfaller MA, Castanheira M, Messer SA, Moet GJ, Jones RN. 2010. Variation in Candida spp. distribution and antifungal resistance rates among bloodstream infection isolates by patient age: report from the SENTRY Antimicrobial Surveillance Program (2008–2009). Diagn Microbiol Infect Dis. 68:278–283. doi:10.1016/j.diagmicrobio.2010.06.015.
  • Sang S, Cheng X, Zhu N, Stark RE, Badmaev V, Ghai G, Rosen RT, Ho CT. 2001. Iridoid glycosides from the leaves of Morinda citrifolia. J Agric Food Chem. 49:4478–4481. doi:10.1021/np010011l.
  • Takashima J, Ikeda Y, Komiyama K, Hayashi M, Kishida A, Ohsaki A. 2007. New constituents from the leaves of Morinda citrifolia. Chem Pharm Bull. 55:343–345. doi:10.1248/cpb.55.343.
  • Van der Bij AK, Van Mansfeld R, Peirano G, Goessens WHF, Sevenn JA, Pitout JDD, Willems R, Van Westreenen M. 2011. First outbreak of VIM-2 metallo-beta-lactamase-producing Pseudomonas aeruginosa in the Netherlands: microbiology, epidemiology and clinical outcomes. Int J Antimicrob Agents. 37:513–518. doi:10.1016/j.ijantimicag.2011.02.010.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.